carole sourbier
United States Food and Drug Administration
Silver Spring, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Editors
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial board
Type at least 3 characters
Shape the future of research in your field
Join the board
Associate Editors
triantafyllos stylianopoulos
University of Cyprus
Nicosia, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
prem s subramaniam
Columbia University Irving Medical Center, Columbia University
New York, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
matthew k. summers
The Ohio State University
Columbus, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
daekyu sun
University of Arizona
Tucson, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
yao tong
The Scripps Research Institute
La Jolla, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
nikos tapinos
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
xiaobing tian
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
kwong tsang
Precision Biologics, Inc.
Rockville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
andrzej tukiendorf
Opole University
Opole, Poland
Associate Editor
Cancer Molecular Targets and Therapeutics
rohit upadhyay
School of Medicine, Tulane University
New Orleans, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
angelina vaseva
The University of Texas Health Science Center at San Antonio
San Antonio, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
marco a. velasco-velazquez
National Autonomous University of Mexico
México City, Mexico
Associate Editor
Cancer Molecular Targets and Therapeutics
rui vitorino
Department of Medical Sciences, University of Aveiro
Aveiro, Portugal
Associate Editor
Cancer Molecular Targets and Therapeutics
jens voortman
Amsterdam University Medical Center
Amsterdam, Netherlands
Associate Editor
Cancer Molecular Targets and Therapeutics
jean-yves winum
Université de Montpellier
Montpellier, France
Associate Editor
Cancer Molecular Targets and Therapeutics